Growth Metrics

BioNexus Gene Lab (BGLC) Non-cash Items (2022 - 2024)

BioNexus Gene Lab's Non-cash Items history spans 3 years, with the latest figure at -$508330.0 for Q4 2024.

  • Quarterly results put Non-cash Items at -$508330.0 for Q4 2024, up 36.06% from a year ago — trailing twelve months through Dec 2024 was -$2.3 million (down 21.1% YoY), and the annual figure for FY2024 was -$2.3 million, down 21.1%.
  • Non-cash Items for Q4 2024 was -$508330.0 at BioNexus Gene Lab, up from -$1.5 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $40263.0 in Q1 2022 to a low of -$1.5 million in Q3 2024.
  • The 3-year median for Non-cash Items is -$88513.0 (2023), against an average of -$391636.8.
  • The sharpest move saw Non-cash Items tumbled 44889.89% in 2023, then skyrocketed 56.66% in 2024.
  • Year by year, Non-cash Items stood at $2246.0 in 2022, then plummeted by 35494.88% to -$794969.0 in 2023, then skyrocketed by 36.06% to -$508330.0 in 2024.
  • According to Business Quant data, Non-cash Items over the past three periods came in at -$508330.0, -$1.5 million, and -$344207.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.